The surgical wounds, plastic, recontraction AND burns market combined is around $800m+. Of that, the full thickness burns market is only about 10% of the addressable $800m market for NovoSorb BTM which I as far as I'm aware, they are NOT selling commercially into yet.
They are however selling into the much larger part of that market right now in wounds, plastic and recontraction, which is why they have built up the sales team and why the market should be very excited.
PNV - Chart, page-148
-
- There are more pages in this discussion • 19,293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.61 |
Change
0.060(2.35%) |
Mkt cap ! $1.801B | |||
| Open | High | Low | Value | Volume |
| $2.53 | $2.61 | $2.46 | $2.873M | 1.124M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1310 | $2.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.62 | 45784 | 5 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |